Crispr Therapeutics (CRSP) is down -9.2%, or -$5.38 to $53.40.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Midday Fly By: HP Enterprise reports Q1 beat, BioNTech announces new company
- Crispr Therapeutics announces proposed convertible senior notes offering
- Crispr Therapeutics AG Surges on Takeover Buzz and Hype
- Crispr Therapeutics rumor highlighted in Betaville blog
- Cathie Wood Loads Up on Biotech Stocks While Trimming Several Tech Positions